Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Barchart

Top 100 Stocks to Buy: Argan Moves Up 40 Spots. Time to Buy?

Argan moved up 40 spots yesterday, from 99th to 59th. Up 134% over the past 12 months, and its weighted alpha is considerably higher, momentum is most definitely on its side. The question is whether you’re too late to buy.

Barchart

Dear BBAI Stock Fans, Mark Your Calendars for December 1

BigBear.ai shares rallied Monday as the management schedules a special shareholder meeting on Dec. 1. Here’s how you should play BBAI stock in the build-up to next week’s event.

Barchart

Find Breakout Stocks & Winning Option Trades with Our TTM Squeeze Lesson for Beginners

Barchart’s top chart strategist explains why John Carter’s TTM Squeeze is a volatility indicator worth adding to your technical analysis tool kit.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Cattle and Lean Hog Bears Rule the Roost. What to Watch Next on the Farm.

Holiday demand and consumer confidence remain two key factors for traders to watch this week.

Barchart

Forget NVDA. This 1 Stronger Tech Stock Can Survive and Thrive in a Selloff. How to Trade It With Options Now.

This company has a compelling case based on its chart, and I’m limiting my downside risk with options.

Barchart

Argentina Beef Quota Just Opened — Why Your Grocery Bill Won't Budge, and Live Cattle Is Still Setting Up for a Monster Move

Bottom line: U.S. cattle supply is still critically tight; imports are a rounding error; the chart is broken; and the trend is down. Watch the Dec seasonal window and three correlated years, but demand confirmation before you swing. Survive first, profit second.

Barchart

Palo Alto Networks' Stock Has Tanked But Its FCF is Strong - Price Target is 15% Higher

Palo Alto Networks' stock is well off its highs, despite producing stellar free cash flow and FCF margins for its fiscal Q1 ending Oct. 31. That implies its price target is at least 15% higher at $212 per share.

Barchart

Read news from The Economist, FT, and more,
with one subscription

The Short-Sellers May Be Right About This Red-Hot Pharma Stock

Palvella Therapeutics (PVLA) is a clinical-stage biopharma stock with no revenue or FDA pipeline. However, the stock has exceptional price momentum with shares up 508% over the past year. PVLA is trading at a new 2-year high and has strong technical indicators. Palvella is highly speculative. It is suitable for...

Barchart

Option Volatility and Earnings Report for November 24 - 28

Earnings season is starting to die down a little, which may come as a relief for some after last week’s market carnage. This week, we only have a few key companies reporting including Alibaba, Zscaler, Deer & Company and Dell Technologies.

Barchart

Chevron's Latest 5-Yr Plan Implies a Major Dividend Hike - CXX Stock Looks Cheap

Chevron's Nov. 12 Investor Day outlined a cash flow plan that implies a potentially sizable dividend hike. It has averaged 7% over the 25 years, beating rivals. Even with a 5% hike in January, CVX stock looks undervalued.

Barchart

3 High-Yield Dividend Gambles Paying Up to 9%- And Wall Street Says ‘Buy’

Three high-yield income plays backed by analysts, offering big upside potential for investors seeking under-the-radar dividend opportunities.

Barchart

3 Simple Options Strategies to Act on Thursday’s Unusual Activity Now

Market volatility has ratcheted up in recent days. The S&P 500 was on course for its worst week in months before Friday’s open. These three strategies rely on Thursday’s unusual options activity for investors wanting to keep things simple.

Barchart

Eli Lilly Stock Joins the $1 Trillion Club as LLY Hits New All-Time Highs

Eli Lilly (LLY) just became the first healthcare company to join the $1 trillion market cap club. Shares are trading at a new all-time high on Friday, Nov. 21. The stock is up 40% in the past year and nearly 80% in the past two years. Analysts remain highly confident,...

Barchart

Corn: Is the Tepid Rally Bearish?

The 2025 U.S. crop year is now fading into the past. Although the U.S. produced a robust corn crop, prices have been trending higher since mid-August, which could reflect commodity cyclicality.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Learn How to Read These Smart Money Warning Signs as Commitments of Traders Data Comes Back Online

Top commodity expert Don Dawson explains how to interpret COT data as this key smart-money indicator returns to markets.

Barchart

ConocoPhillips' 3.84% Dividend Yield Implies COP Stock Could be 24% Undervalued

ConocoPhillips Inc. raised its dividend by 7.7%, giving COP stock a 3.84% annual yield. That is well over its historical average, implying COP could be worth 24% more. One way to play it is to short out-of-the-money put options.

Barchart

This Stock’s Dividend Has Risen 1.5X in 2 Years. Is It a Buy Here?

Disney has increased its 2026 dividend by 50% and the payout has risen 1.5X since 2023. Is DIS stock a buy for the dividend hike?

Barchart

Silver Stalled- Was the Recent Record High the Top?

Silver prices reached a new nominal record high on November 13, 2025, rising to $54.4150 per ounce. Silver rose above the 2011 and 1980 highs before correcting. Silver prices corrected to just above $49.115 per ounce and were back above the $50 level on November 20, which could signal that…

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

AMD Stock Is the ‘King of the Hill’ Right Now. Should You Buy Shares Here?

Wall Street eyes AMD as a new AI leader, yet rich multiples mean patience may be required.

Barchart

This Stock Is Up 704% in 2025 But Has No Products to Its Name

Relmada Therapeutics (RLMD) is a clinical-stage pharma company with no commercialized products and a $141 million market cap. RLMD has shown strong technical momentum, gaining 440% since August. Shares have a 100% “Buy” technical opinion from Barchart. Despite technical strength, RLMD lacks revenue, faces pipeline setbacks, and is rated “Hold”...

Barchart

The Bull and Bear Cases for Gold, Silver Prices in November 2025

Here’s what traders in gold and silver futures prices should be watching at the end of 2025.

Barchart

Here’s How You Can Have Your Cake with AMD Stock and Eat It Too – With Just 6.6% Downside Risk

Here’s another option collar setup that lets you chase AMD stock back to its all-time highs while capping the risk.

Barchart

Large, Unusual Call Options Trading in GOOGL Stock Highlights Its Value

A large tranche of deep out-of-the-money GOOGL call options that expire in over a year and a half highlights the underlying value of Alphabet stock. This is seen in today's Barchart Unusual Stock Options Activity Report.

Barchart

This Blue-Chip Stock Is a Heavy Weight in Weight-Loss Drugs

Eli Lilly (LLY) stands out for its diversified pharmaceutical portfolio, robust pipeline, and strategic acquisitions that are fueling growth. LLY has strong technical momentum and is trading at new all-time highs. Shares are up 43% over the past year. Analyst sentiment is overwhelmingly positive, with most major firms rating LLY...

Barchart

This Consumer Stock is Already in a Bear Market. Smart Money Sees 20% More Downside Ahead.

Our top chart strategist explains what today’s heavy options volume on CAVA stock is saying about the short-term forecast.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.